15-3-3　ⓔ文献

  1. Imura H, Nakao K, et al: Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. N Engl J Med, 1993; 329: 683–689.

  2. Juul KV, Schroeder M, et al: National surveillance of central diabetes insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients. J Clin Endocrinol Metab, 2014; 99: 2181–2187.

  3. 厚生労働科学研究費補助金難治性疾患克服研究事業 間脳下垂体機能障害に関する調査研究班：中枢性尿崩症の病因，水バランスの実態，および渇感障害が生命予後に及ぼす影響. 平成25年度 総括・分担研究報告書，2014; 76–83.

  4. Arima H, Azuma Y, et al: Central diabetes insipidus. Nagoya J Med Sci, 2016; 78: 349–358.

  5. Babey M，Kopp P, et al: Familial forms of diabetes insipidus: clinical and molecular characteristics. Nat Rev Endocrinol, 2011; 7: 701–714.

  6. Shimatsu A, Oki Y, et al: Pituitary and stalk lesions (infundibulo–hypophysitis) associated with immunoglobulin G4–related systemic disease: an emerging clinical entity. Endocr J, 2009; 56: 1033–1041.

  7. 厚生労働科学研究費補助金難治性疾患等政策研究事業 間脳下垂体機能障害に関する調査研究班：バゾプレシン分泌低下症 (中枢性尿崩症) の診断と治療の手引き. 間脳下垂体機能障害の診断と治療の手引き (平成30 年度改訂)，日本内分泌学会，2019; 15–17.

  8. Takagi H, Hagiwara D, et al: Diagnosis of central diabetes insipidus using a vasopressin radioimmunoassay during hypertonic saline infusion. Endocr J, 2020; 67: 267–274.

  9. Fujisawa I: Magnetic resonance imaging of the hypothalamic–neurohypophyseal system. J Neuroendocrinol, 2004; 16: 297–302.

  10. Arima H, Wakabayashi T, et al: Adipsia increases risk of death in patients with central diabetes insipidus. Endocr J, 2014; 61: 143–148.